ATE195940T1 - Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen - Google Patents
Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungenInfo
- Publication number
- ATE195940T1 ATE195940T1 AT96911009T AT96911009T ATE195940T1 AT E195940 T1 ATE195940 T1 AT E195940T1 AT 96911009 T AT96911009 T AT 96911009T AT 96911009 T AT96911009 T AT 96911009T AT E195940 T1 ATE195940 T1 AT E195940T1
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- taxol derivatives
- taxol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9503868A FR2732342B1 (fr) | 1995-04-03 | 1995-04-03 | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR1996/000487 WO1996031493A1 (fr) | 1995-04-03 | 1996-04-01 | Nouveaux taxoïdes, leur preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE195940T1 true ATE195940T1 (de) | 2000-09-15 |
Family
ID=9477663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96911009T ATE195940T1 (de) | 1995-04-03 | 1996-04-01 | Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US5959125A (de) |
| EP (1) | EP0821680B1 (de) |
| JP (1) | JPH11504004A (de) |
| KR (1) | KR19980703520A (de) |
| CN (1) | CN1073106C (de) |
| AP (1) | AP784A (de) |
| AR (1) | AR002730A1 (de) |
| AT (1) | ATE195940T1 (de) |
| AU (1) | AU703918B2 (de) |
| BG (1) | BG62964B1 (de) |
| BR (1) | BR9604799A (de) |
| CA (1) | CA2214322C (de) |
| CZ (1) | CZ287430B6 (de) |
| DE (1) | DE69610085T2 (de) |
| DK (1) | DK0821680T3 (de) |
| EA (1) | EA000726B1 (de) |
| ES (1) | ES2151155T3 (de) |
| FR (1) | FR2732342B1 (de) |
| GE (1) | GEP19991872B (de) |
| GR (1) | GR3034203T3 (de) |
| HU (1) | HUP9802042A3 (de) |
| IL (1) | IL117760A (de) |
| MX (1) | MX9707427A (de) |
| NO (1) | NO974563L (de) |
| NZ (1) | NZ305898A (de) |
| PL (1) | PL322581A1 (de) |
| PT (1) | PT821680E (de) |
| RO (1) | RO115879B1 (de) |
| SK (1) | SK282047B6 (de) |
| TW (1) | TW347389B (de) |
| WO (1) | WO1996031493A1 (de) |
| ZA (1) | ZA962633B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6495579B1 (en) | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
| FR2764118B1 (fr) * | 1997-05-30 | 2000-08-04 | Thomson Csf | Transistor bipolaire stabilise avec elements isolants electriques |
| US6156789A (en) * | 1998-03-17 | 2000-12-05 | Rhone-Poulenc Rorer S.A. | Method for treating abnormal cell proliferation in the brain |
| EP1176957A1 (de) * | 1999-05-03 | 2002-02-06 | Aventis Pharma S.A. | Verfahren zur behandlung von abnormaler zellproliferation des gehirns |
| JP2003522171A (ja) | 2000-02-02 | 2003-07-22 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | 抗腫瘍剤としてのｃ１０カーボネート置換タキサン |
| US6649632B2 (en) * | 2000-02-02 | 2003-11-18 | Fsu Research Foundation, Inc. | C10 ester substituted taxanes |
| NZ514407A (en) * | 2000-02-02 | 2004-12-24 | Univ Florida State Res Found | C10 carbamoyloxy substituted taxanes as antitumor agents |
| JP2004339475A (ja) * | 2003-02-03 | 2004-12-02 | Merck Patent Gmbh | フッ化物、オキシフッ化物、フルオロ硫化物および／またはオキシフルオロ硫化物に基づく真珠光沢顔料 |
| CA2526278A1 (en) * | 2003-05-20 | 2004-12-02 | Aronex Pharmaceuticals, Inc. | Combination chemotherapy comprising a liposomal platinum complex |
| HN2005000054A (es) | 2004-02-13 | 2009-02-18 | Florida State University Foundation Inc | Taxanos sustituidos con esteres de ciclopentilo en c10 |
| AU2006214498A1 (en) * | 2005-02-14 | 2006-08-24 | Florida State University Research Foundation, Inc. | C10 cyclopropyl ester substituted taxane compositions |
| JP2011517455A (ja) * | 2008-03-31 | 2011-06-09 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | Ｃ（１０）エチルエステルおよびｃ（１０）シクロプロピルエステル置換タキサン |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO302520B1 (no) * | 1992-07-01 | 1998-03-16 | Bristol Myers Squibb Co | Fluortaxoler, mellomprodukt til fremstilling derav, samt farmasöytisk preparat inneholdende dem |
| US5254580A (en) * | 1993-01-19 | 1993-10-19 | Bristol-Myers Squibb Company | 7,8-cyclopropataxanes |
| FR2698871B1 (fr) * | 1992-12-09 | 1995-02-24 | Rhone Poulenc Rorer Sa | Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent. |
| IL107950A (en) * | 1992-12-15 | 2001-04-30 | Upjohn Co | b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them |
-
1995
- 1995-04-03 FR FR9503868A patent/FR2732342B1/fr not_active Expired - Fee Related
-
1996
- 1996-04-01 TW TW085103805A patent/TW347389B/zh active
- 1996-04-01 ES ES96911009T patent/ES2151155T3/es not_active Expired - Lifetime
- 1996-04-01 MX MX9707427A patent/MX9707427A/es not_active IP Right Cessation
- 1996-04-01 NZ NZ305898A patent/NZ305898A/xx unknown
- 1996-04-01 AP APAP/P/1997/001094A patent/AP784A/en active
- 1996-04-01 AU AU54028/96A patent/AU703918B2/en not_active Ceased
- 1996-04-01 BR BR9604799A patent/BR9604799A/pt not_active Application Discontinuation
- 1996-04-01 DE DE69610085T patent/DE69610085T2/de not_active Expired - Fee Related
- 1996-04-01 CN CN96192946A patent/CN1073106C/zh not_active Expired - Fee Related
- 1996-04-01 GE GEAP19963965A patent/GEP19991872B/en unknown
- 1996-04-01 SK SK1333-97A patent/SK282047B6/sk unknown
- 1996-04-01 KR KR1019970706924A patent/KR19980703520A/ko not_active Application Discontinuation
- 1996-04-01 US US08/930,561 patent/US5959125A/en not_active Expired - Fee Related
- 1996-04-01 IL IL11776096A patent/IL117760A/en not_active IP Right Cessation
- 1996-04-01 RO RO97-01817A patent/RO115879B1/ro unknown
- 1996-04-01 CA CA002214322A patent/CA2214322C/fr not_active Expired - Fee Related
- 1996-04-01 PT PT96911009T patent/PT821680E/pt unknown
- 1996-04-01 HU HU9802042A patent/HUP9802042A3/hu unknown
- 1996-04-01 DK DK96911009T patent/DK0821680T3/da active
- 1996-04-01 EA EA199700288A patent/EA000726B1/ru not_active IP Right Cessation
- 1996-04-01 CZ CZ19973109A patent/CZ287430B6/cs not_active IP Right Cessation
- 1996-04-01 AT AT96911009T patent/ATE195940T1/de not_active IP Right Cessation
- 1996-04-01 PL PL96322581A patent/PL322581A1/xx unknown
- 1996-04-01 JP JP8530026A patent/JPH11504004A/ja not_active Ceased
- 1996-04-01 EP EP96911009A patent/EP0821680B1/de not_active Expired - Lifetime
- 1996-04-01 WO PCT/FR1996/000487 patent/WO1996031493A1/fr not_active Application Discontinuation
- 1996-04-02 ZA ZA962633A patent/ZA962633B/xx unknown
- 1996-04-03 AR ARP960102049A patent/AR002730A1/es not_active Application Discontinuation
-
1997
- 1997-10-02 NO NO974563A patent/NO974563L/no not_active Application Discontinuation
- 1997-10-03 BG BG101940A patent/BG62964B1/bg unknown
-
2000
- 2000-08-31 GR GR20000400100T patent/GR3034203T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE250593T1 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
| DE69606028T2 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung | |
| DE60142890D1 (de) | 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung | |
| DE69131813D1 (de) | Amido-3-Pyrazol-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen | |
| DE69928260D1 (de) | Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE69616323D1 (de) | Aromatische verbindungen und diese enthaltende pharmazeutische zusammenstellungen | |
| DE69604889T2 (de) | Mit ortho-Adamantylgruppe substituierte diaromatische Verbindungen, diese enthaltende pharmazeutische und kosmetische Zusammensetzungen und Verwendungen | |
| ATE297935T1 (de) | 2-(iminomethyl)aminophenyl-derivate, deren herstellung, verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen | |
| DE69608680D1 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
| DE69618210D1 (de) | Aromatische verbindungen und diese enthaltende pharmazeutische zusammenstellungen | |
| DE69815094D1 (de) | 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen | |
| ATE303363T1 (de) | 4-aminopyridinderivate, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE222897T1 (de) | Substituierte thiazolidinedione derivate, ihre herstellung und pharmazeutische zusammensetzungen,die sie enthalten | |
| EE04493B1 (et) | Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks | |
| DE59814412D1 (de) | Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate | |
| ATE195940T1 (de) | Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
| ATE204266T1 (de) | Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE515995T1 (de) | N-(5-thioxo-l-propyl)-l-cystein und derivate, deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen. | |
| DE69520870T2 (de) | Esculetin Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammenstellung | |
| DE69907735D1 (de) | Melatoninderivate und diese enthaltende pharmazeutische zubereitung | |
| DE69942424D1 (de) | Neuartige agarofuran derivate, ihre herstellung, pharmazeutische zusammensetzungen, die diese enthalten und ihre verwendung als medizin | |
| DE69715247T2 (de) | Auf quinupristin und dalfopristin basierte stabilisierte pharmazeutische zusammensetzung, und deren zubereitung | |
| DE60126046D1 (de) | Bizyklische Amino-Pyrazon Derivate, deren Herstellung und pharmazeutische Zusammensetzungen | |
| DE69725166D1 (de) | Substituierte benzamidderivate und diese enthaltende pharmazeutische zusammensetzung | |
| ATE204265T1 (de) | Neue taxoide, herstellung und pharmazeutische zusammensetzungen diese enthaltend |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |